Powered exoskeleton

Exoskeleton Market worth $3,340 million by 2026 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Wednesday, June 9, 2021
Robotics, Technology, Assistive technology, Medical robotics, Prosthetics, Ekso Bionics, Powered exoskeleton, Exoskeleton, Cyberdyne, Ottobock

The exoskeleton market includes major Tier I and II players like Ottobock (Germany), DIH Medical (China), CYBERDYNE (Japan), Ekso Bionics.

Key Points: 
  • The exoskeleton market includes major Tier I and II players like Ottobock (Germany), DIH Medical (China), CYBERDYNE (Japan), Ekso Bionics.
  • These players have a strong market presence for exoskeleton across various countries in North America, Europe, APAC, and RoW.
  • Thus, the intensifying need for human augmentation in industrial and military sectors creates opportunities for the growth of the exoskeleton market.
  • The high cost of powered exoskeletons leads to a higher market share of the technology compared to passive exoskeletons.

Exoskeleton Market worth $3,340 million by 2026 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Wednesday, June 9, 2021
Robotics, Technology, Assistive technology, Medical robotics, Prosthetics, Ekso Bionics, Powered exoskeleton, Exoskeleton, Cyberdyne, Ottobock

The exoskeleton market includes major Tier I and II players like Ottobock (Germany), DIH Medical (China), CYBERDYNE (Japan), Ekso Bionics.

Key Points: 
  • The exoskeleton market includes major Tier I and II players like Ottobock (Germany), DIH Medical (China), CYBERDYNE (Japan), Ekso Bionics.
  • These players have a strong market presence for exoskeleton across various countries in North America, Europe, APAC, and RoW.
  • Thus, the intensifying need for human augmentation in industrial and military sectors creates opportunities for the growth of the exoskeleton market.
  • The high cost of powered exoskeletons leads to a higher market share of the technology compared to passive exoskeletons.

Global Wearable Robotic Exoskeleton Market 2021-2031: Increasing Demand for Exoskeletons in Multiple Domains & Rising Investments by Major Industry Players and Establishment of Various Start-Ups

Retrieved on: 
Wednesday, May 19, 2021
Industrial robotics, Medical robotics, Body armor, Powered exoskeleton, Technology, Branches of biology, Articles, Exoskeleton

The North America region includes the U.S. and Canada, where the U.S. is expected to acquire a major share in 2031 due to the increase in the investment by the exoskeleton manufacturing companies in the country.\nThe wearable robotic exoskeleton market has gained huge importance in the past few years.

Key Points: 
  • The North America region includes the U.S. and Canada, where the U.S. is expected to acquire a major share in 2031 due to the increase in the investment by the exoskeleton manufacturing companies in the country.\nThe wearable robotic exoskeleton market has gained huge importance in the past few years.
  • This is due to the rising geriatric population across the globe and increasing awareness about exoskeletons among the end users.
  • Several government agencies, non-profit organizations, and associations have started investing in the market, thereby generating a lucrative market for new players.\nThe global wearable robotic exoskeleton market research provides the market information for segmentations, such as end user based on application and components in terms of hardware and software.
  • A brief description of soft exoskeletons and hard exoskeletons along with their market potential, is also explained in the report.\nThe global wearable robotic exoskeleton market is segregated by region under four major regions, namely, North America, Europe, APAC, and Rest-of-the-World.

Ekso Bionics® Announces Expanded Partnership with Kindred Healthcare for Multi-Unit EksoNR Order

Retrieved on: 
Tuesday, May 11, 2021
Robotics, Ekso Bionics, Medical robotics, Powered exoskeleton, Health, Kindred Healthcare, Technology, Kindred

b'RICHMOND, Calif., May 11, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the \xe2\x80\x9cCompany\xe2\x80\x9d), an industry leader in exoskeleton technology for medical and industrial use, today announced an expanded partnership with Kindred Healthcare, LLC ("Kindred") bringing EksoNR, the most clinically used robotic exoskeleton, to four of Kindred\xe2\x80\x99s Long-Term Acute Care (\xe2\x80\x9cLTAC\xe2\x80\x9d) Hospitals in the U.S.

Key Points: 
  • b'RICHMOND, Calif., May 11, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the \xe2\x80\x9cCompany\xe2\x80\x9d), an industry leader in exoskeleton technology for medical and industrial use, today announced an expanded partnership with Kindred Healthcare, LLC ("Kindred") bringing EksoNR, the most clinically used robotic exoskeleton, to four of Kindred\xe2\x80\x99s Long-Term Acute Care (\xe2\x80\x9cLTAC\xe2\x80\x9d) Hospitals in the U.S.
  • The LTAC locations incorporating EksoNR technology will be at Kindred\xe2\x80\x99s Florida hospitals in Green Cove Springs, Tampa/St.
  • Pete, Fort Lauderdale, and Melbourne.\n\xe2\x80\x9cWe are excited to expand our partnership with Ekso Bionics and build on our leadership position in acute patient services with the addition of these innovative EksoNR devices,\xe2\x80\x9d said Mike Warrington, President of Kindred Healthcare\xe2\x80\x99s Hospital Division.
  • To learn more about Ekso Bionics please visit the Company\xe2\x80\x99s website at www.eksobionics.com or follow @EksoBionics on Twitter.

ReWalk Robotics to Report First Quarter 2021 Financial Results on May 11, 2021

Retrieved on: 
Friday, May 7, 2021
Assistive technology, Robotics, Technology, Science and technology, Medical robotics, ReWalk, Prosthetics, Powered exoskeleton, XC2

b'ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.\xc2\xa0 ReWalk\xe2\x80\x99s mission is to fundamentally change the quality of life for individuals with lower limb disability through the creation and development of market leading robotic technologies.

Key Points: 
  • b'ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.\xc2\xa0 ReWalk\xe2\x80\x99s mission is to fundamentally change the quality of life for individuals with lower limb disability through the creation and development of market leading robotic technologies.
  • Founded in 2001, ReWalk has headquarters in the U.S., Israel and Germany.
  • For more information on the ReWalk systems, please visit www.rewalk.com .\nReWalk\xc2\xae is a registered trademark of ReWalk Robotics Ltd. in Israel and the Unites States.\n'

Ekso expands its robotic exoskeleton adoption in Asia Pacific

Retrieved on: 
Monday, April 26, 2021
Robotics, Medical robotics, Technology, Ekso Bionics, Science and technology, Assistive technology, Prosthetics, Powered exoskeleton

b'SYDNEY, Australia, April 26, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics, an industry leader in exoskeleton technology, with its Asia headquarters in Singapore, announces its partnership with Royal Rehab in Australia, further scaling the use of its robotic exoskeleton across the Asia Pacific region.\nEkso is the most clinically used robotic exoskeleton globally and in Asia and has helped patients take more than 130 million steps globally.

Key Points: 
  • b'SYDNEY, Australia, April 26, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics, an industry leader in exoskeleton technology, with its Asia headquarters in Singapore, announces its partnership with Royal Rehab in Australia, further scaling the use of its robotic exoskeleton across the Asia Pacific region.\nEkso is the most clinically used robotic exoskeleton globally and in Asia and has helped patients take more than 130 million steps globally.
  • Established in 1899, Royal Rehab is highly regarded for its state-wide specialist brain and spinal cord injury rehabilitation.
  • Royal Rehab is managed by an experienced and specialised team dedicated to maximising life skills, abilities, and independence.
  • Ekso Bionics is the only exoskeleton company to offer technologies that range from helping those with paralysis to stand up and walk, to enhancing human capabilities on job sites across the globe.

Ekso expanding its robotic exoskeleton adoption across Asia

Retrieved on: 
Monday, April 26, 2021
Robotics, Ekso Bionics, Technology, Medical robotics, Science and technology, Prosthetics, Assistive technology, Powered exoskeleton

b'SYDNEY, Australia, April 25, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics, an industry leader in exoskeleton technology, with presence in Hong Kong, announces its partnership with Royal Rehab in Australia, further scaling the use of its robotic exoskeleton across the Asia Pacific region.\nWith Ekso Bionics\xe2\x80\x99 recent expansion plan in Asia Pacific, EksoNRs are now in Hong kong, Singapore, Malaysia, Taiwan and Australia.

Key Points: 
  • b'SYDNEY, Australia, April 25, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics, an industry leader in exoskeleton technology, with presence in Hong Kong, announces its partnership with Royal Rehab in Australia, further scaling the use of its robotic exoskeleton across the Asia Pacific region.\nWith Ekso Bionics\xe2\x80\x99 recent expansion plan in Asia Pacific, EksoNRs are now in Hong kong, Singapore, Malaysia, Taiwan and Australia.
  • Established in 1899, Royal Rehab is highly regarded for its state-wide specialist brain and spinal cord injury rehabilitation.
  • Royal Rehab is managed by an experienced and specialised team dedicated to maximising life skills, abilities, and independence.
  • Ekso Bionics is the only exoskeleton company to offer technologies that range from helping those with paralysis to stand up and walk, to enhancing human capabilities on job sites across the globe.

Ekso expanding its robotic exoskeleton adoption across Asia

Retrieved on: 
Monday, April 26, 2021
Robotics, Medical robotics, Ekso Bionics, Technology, Science and technology, Prosthetics, Assistive technology, Powered exoskeleton

b'SYDNEY, Australia, April 26, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics, an industry leader in exoskeleton technology, with presence in Malaysia, announces its partnership with Royal Rehab in Australia, further scaling the use of its robotic exoskeleton across the Asia Pacific region.\nWith Ekso Bionics\xe2\x80\x99 recent expansion plan in Asia Pacific, EksoNRs are now in Malaysia, Singapore, Hong Kong, Taiwan and Australia.

Key Points: 
  • b'SYDNEY, Australia, April 26, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics, an industry leader in exoskeleton technology, with presence in Malaysia, announces its partnership with Royal Rehab in Australia, further scaling the use of its robotic exoskeleton across the Asia Pacific region.\nWith Ekso Bionics\xe2\x80\x99 recent expansion plan in Asia Pacific, EksoNRs are now in Malaysia, Singapore, Hong Kong, Taiwan and Australia.
  • This partnership further solidifies our goal to increase accessibility of our robotic technology across Asia Pacific\xe2\x80\x99\xe2\x80\x99\nThe EksoNR is set to revolutionise rehabilitation practice in Malaysia and Asia with its ability to help improve patients recovery following stroke, acquired brain injury and spinal cord injury.
  • Established in 1899, Royal Rehab is highly regarded for its state-wide specialist brain and spinal cord injury rehabilitation.
  • Ekso Bionics is the only exoskeleton company to offer technologies that range from helping those with paralysis to stand up and walk, to enhancing human capabilities on job sites across the globe.

Global Wearable Robotic Exoskeleton Market Forecast 2021-2031: Impact of Emerging Technologies on Wearable Robotic Exoskeletons - ResearchAndMarkets.com

Retrieved on: 
Tuesday, April 20, 2021
Biotechnology, Medical devices, Hardware, Health, Technology, Medical robotics, Body armor, Powered exoskeleton, Technology, Science and technology, Articles

b'The "Wearable Robotic Exoskeleton Market - A Global and Regional Analysis: Focus on Component, End User, Application, and Operation - Analysis and Forecast, 2021-2031" report has been added to ResearchAndMarkets.com\'s offering.\nThe global wearable robotic exoskeleton industry analysis projects the market to have a significant growth rate of 32.68% based on the value and a growth rate of 34.01% based on volume during the forecast period 2021-2031.

Key Points: 
  • b'The "Wearable Robotic Exoskeleton Market - A Global and Regional Analysis: Focus on Component, End User, Application, and Operation - Analysis and Forecast, 2021-2031" report has been added to ResearchAndMarkets.com\'s offering.\nThe global wearable robotic exoskeleton industry analysis projects the market to have a significant growth rate of 32.68% based on the value and a growth rate of 34.01% based on volume during the forecast period 2021-2031.
  • The North America region is expected to dominate the market by 2031 with a share of 38.20%.
  • This is due to the rising geriatric population across the globe and increasing awareness about exoskeletons among the end users.
  • Several government agencies, non-profit organizations, and associations have started investing in the market, thereby generating a lucrative market for new players.\nThe global wearable robotic exoskeleton market research provides the market information for segmentations, such as end user based on application and components in terms of hardware and software.

Worldwide Artificial Organ and Bionics Industry to 2025 - Advantageous in Comparison Prosthetics Presents Opportunities

Retrieved on: 
Tuesday, April 13, 2021
Life sciences, Prosthetics, Robotics, Technology, Ekso Bionics, Biotechnology, Biological engineering, Medical robotics, Bionics, Powered exoskeleton, Artificial organ, Edwards Lifesciences

This has been a major boost for the artificial organ bionics market, as the patients cannot afford to wait in queue since the stakes are very high.

Key Points: 
  • This has been a major boost for the artificial organ bionics market, as the patients cannot afford to wait in queue since the stakes are very high.
  • Bionics and artificial organs are able to cater to the needs of those in need of organ transplantations and replacements.
  • In February 2020, Ekso Bionics Holdings, Inc. collaborated with Kindred Healthcare, LLC to pilot EksoNR - a robotic exoskeleton, in their long-term acute care hospitals.\n2.
  • In April 2019, Edwards Lifesciences Corporation acquired CAS Medical Systems, Inc., a medical technology company dedicated to non-invasive brain and tissue oxygenation monitoring.\n3.